# Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

> **NCT03130270** · PHASE2 · UNKNOWN · sponsor: **Guilin Medical University, China** · enrollment: 29 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Apatinib mesylate tablet

## Key facts

- **NCT ID:** NCT03130270
- **Lead sponsor:** Guilin Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2019-04-08
- **Final completion:** 2019-12-08
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2018-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130270, "Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03130270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*